Early diagnosis of acute kidney injury

Central European Journal of Medicine - Tập 5 - Trang 527-534 - 2010
Marius G. Dehne1, Bernd Hartmann2, Christian Katzer2, Rainer Röhrig2
1Department of Anesthesiology, Intensive Care Medicine, Emergency medicine and pain therapy, Hospital Wittlich, Wittlich, Germany
2Staff Anesthesiologist, Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen, Germany

Tóm tắt

There is a considerable lack of data concerning the diagnostic testing for kidney damage after surgical procedures. In this situation the most important variables should be examined with respect to their clinical informative value, the costs associated with their analysis, and their potential use in routine diagnostic testing. Forty patients in the surgical intensive care unit (ICU) with acute kidney injury (AKI) that developed during their stay of 13–18 (median, 16) days in the ICU were examined daily during their entire ICU admission. The bulk of the laboratory research consisted of the measurement of creatinine, urea, and sodium, as well as clearances rates and diuresis. Various tests for diagnosing regional renal damage (enzymes and proteins) were also carried out. The included photometry, nephelometric analysis, and ELISA (enzyme-linked immunosorbent assay). Five days before an AKI became evident, pathologic levels of urinary α1-microglobulin (tubular parameter) could already be confirmed. Serum creatinine values or creatinine clearance indicated the presence of disease only 1 day before the AKI was seen. Our results show that determination of α1-microglobulin and immunoglobulin G (glomerular parameter) levels, in addition to the level of urea in serum, be recommended for patients in surgical intensive care units who are at risk for AKI. Use of these procedures can achieve early recognition and sufficiently precise localization of renal damage.

Tài liệu tham khảo

Byrick R.J., Rose D.K.: Pathophysiology and prevention of acute renal failure: The role of the anaesthesist, Can. J. Anaesth. 1990, 37,457–467

Sural S., Sharma R.K., Singhal M., Sharma A.P., Kher V., Arora P., Gupta A., Gulati S.: Etiology, prognosis, and outcome of post-operative acute renal failure, Ren. Fail. 2000, 1,87–97

Pickering J.W., Endre Z.H.: Secondary prevention of acute kidney injury, Curr. Opin. Crit. Care 2009, 15(6),488–497

Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P., Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit. Care 2004, 8(4), 204–212

Kellum J.A., Acute kidney injury, Crit. Care Med. 2008, 36(4),141–145

Kellen M., Aronson S., Roizen M., Barnard J., Thisted R., Predictive and Diagnostic Tests of Renal Failure: A Review, Anesth. Analg. 1994, 78,134–142

Dati F., Lammers M., Immunochemical Methods for Determination of Urinary Proteins in Kidney Disease, J. Fed. Clin. Chem. 1989, 1,68–77

Simane Z.J., N-Acetyl-b-D-Glucosaminidase; in Jung K, Mattenheimer H, Burchardt U (eds), Urinary Enzymes in Clinical and Experimental Medicine, Berlin, Springer, 1992, pp118–124

Scherberich J.E., Aminopeptidase A (Angiotensinase A), in Jung K, Mattenheimer H, Burchardt U (eds), Urinary Enzymes in Clinincal and Experimental Medicine. Berlin, Springer, 1992, pp 116–112

Szczech L.A., The development of urinary biomarkers for kidney disease is the search for our renal troponin, J Am. Soc. Nephrol. 2009, 20(8),1656–1657

Dixon B.S., Anderson R.J., Nonoliguric acute renal failure, Am. J. Kidney Dis. 1985, 6,71–80

Hartl W.H., Jauch K.W., Post-aggression metabolism: attempt at a status determination, Infusionsther. Transfusionsmed. 1994, 2,30–40

Lynn K.L., Marshall R.D., Excretion of Tamm-Horsfall glycoprotein in renal disease, Clin. Nephrol. 1984, 22,253–257

Itoh Y., Enomoto H., Takagi K., Kawai, T., Clinical usefulness of serum alpha 1-microglobulin as a sensitive indicator for renal insufficiency, Nephron 1983, 33,69–70

Wedeen R.P., Udasin I., Fiedler N., Urinary biomarkers as indicators of renal disease, Ren. Fail. 1999, 21,241–249

Wolf G., Thaiss F., Scherberich J.E., Schoeppe W., Stahl R.A., Glomerular angiotensinase A in the rat: increase of enzyme activity following renal ablation, Kidney Int. 1990, 38,862–868

Hotta O., Sugai H., Kitamura H., Yusa N., Taguma Y., Predictive value of urinary microcholesterol (mCHO) levels in patients with progressive glomerular disease. Kidney Int. 2004, 66,2374–2381

Higuchi H., Adachi Y., Renal function in surgical patients after administration of low-flow sevoflurane and amikacin, J. Anesth. 2002, 16,17–22

Scherberich J.E., Wolf G., Albers C., Nowack A., Stuckhardt C., Schoeppe W., Glomerular and tubular membrane antigens reflecting cellular adaptation in human renal failure, Kidney Int. Suppl. 1989, 27,38–51

Mueller P.W., MacNeil M.L., Steinberg K.K., Stabilization of alanine aminopeptidase, gammaglutamyltransferase and N-acetyl-beta-D-glucosaminidase in normal urine, Arch. Environ. Contam. Toxicol. 1986, 15,343–358

Mattenheimer H., Frolke W., Grotsch H., Mahrun D., Simane Z.J., Recommendation for the measurement of “alanine aminopeptidase” in urine, J. Clin. Chem. Clin. Biochem. 1988, 26,635–644

Dehne M.G., Mühling J., Papke G., Nopens H., Kuntzsch U., Hempelmann G., Unrecognized renal damage in critically ill patients, Ren. Fail. 1999, 21,695–706

Teppo A. M., von Willebrand E., Honkanen E., Ahonen J., Gronhagen-Riska C., Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1? Transplantation 2001, 71,1113–1119

Gauer S., Yao J., Schoecklmann H.O., Sterzel R.B., Adhesion molecules in the glomerular mesangium, Kidney Int. 1997, 51,1447–1453

Gobé Glenda C., Willgoss D., Hogg N., Schoch E., Endre Z., Cell survival or death in renal tubular epithelium after ischemia-reperfusion injury, Kidney Int. 1999, 56,1299–1304

Rothlein R., Kennedy C., Czajkowski M., Barton R.W., Generation and characterization of an antiidiotypic antibody specific for intercellular adhesion molecule-1, Int. Arch. Allergy Immunol. 1993, 100,121–127

Bechtel U., Scheuer R., Landgraf R., Konig A., Feucht H.E., Assessment of soluble adhesion molecules (sICAM-1, sVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine. Clinical monitoring of renal allograft recipients, Transplantation 1994, 58,905–911

Gearing A.J.H., Hemingway I., Pigott R., Hughes J., Rees A.J., Cashman S.J., Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: Pathological significance, Ann. N. Y. Acad. Sci. 1992, 667,324–331

Bevilacqua M.P., Stengelin S., Gimbrone M.A. Jr, Seed B., Endothelial Leukocyte Adhesion Molecule 1: An Inducible Receptor for Neutrophils Related to Complement Regulatory Proteins and Lectins, Science 1989, 243,1160–1164

Kelly K. J., Williams W.W., Colvin R.B., Meehan S.M., Springer T.A., Guiterrez-Ramos J.C., Bonventre J.V., Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury, J. Clin. Invest. 1996, 97,1056–1062

Thông tin
Thông tin xuất bản

Central European Journal of Medicine

Tập 5

527-534

Thông tin tác giả